Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thierry Velu
Monoclonal Anti-Mage-3 CTL Responses in Melanoma Patients Displaying Tumor Regression After Vaccination With a Recombinant Canarypox Virus
Journal of Immunology
Allergy
Immunology
Related publications
Correlation Between Tumor Regression and T Cell Responses in Melanoma Patients Vaccinated With a MAGE Antigen
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The Anti-Tumor Immune Response Induced by a Combination of MAGE-3/MAGE-n-derived Peptides
Oncology Reports
Medicine
Cancer Research
Oncology
Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients With Merkel Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma
New England Journal of Medicine
Medicine
Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Multispecificity of a Recombinant Anti-Ras Monoclonal Antibody
Journal of Molecular Recognition
Structural Biology
Molecular Biology
Vaccination With a Recombinant Saccharomyces Cerevisiae Expressing a Tumor Antigen Breaks Immune Tolerance and Elicits Therapeutic Antitumor Responses
Clinical Cancer Research
Cancer Research
Oncology
P53 as a Target for Cancer Vaccines: Recombinant Canarypox Virus Vectors Expressing P53 Protect Mice Against Lethal Tumor Cell Challenge.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
LAG-3 and PD-1+LAG-3 Inhibition Promote Anti-Tumor Immune Responses in Human Autologous Melanoma/T Cell Co-Cultures
OncoImmunology
Oncology
Allergy
Immunology
